Highlights Gland Pharma Limited

Equities

GLAND

INE068V01023

Market Closed - NSE India S.E. Other stock markets 07:43:52 2024-05-31 am EDT			5-day change	1st Jan Change
1,840 ^INR	-0.54%		-2.43%	-4.38%

May. 31	Gland Pharma Limited Announces Resignation of C.S. Venkatesan as Sr. Vice President (R&D) and SMP, Effective June 30, 2024 and July 1, 2024 Respectively	CI
May. 24	Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India	MT

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Gland Pharma Gets Zero Observations from US FDA for API Facility in Andhra Pradesh, India	May. 24	MT
Gland Pharma Posts Surge in Fiscal Q4 Consolidated Net Profit	May. 23	MT
Gland Pharma Limited Board Recommends Final Dividend for the Fiscal Year Ending March 31, 2024	May. 22	CI
Gland Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	May. 22	CI
Gland Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2024	May. 22	CI
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Edaravone Injection	May. 07	CI
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Plerixafor Injection	May. 07	CI
KKR to buy India's Healthium Medtech at $839 million valuation, sources say	May. 06	RE
Gland Pharma Gets US FDA's Final Approval for Generic Drug for Luteinizing Hormone Surges	Apr. 29	MT
Gland Pharma Receives Approval for Cetrorelix Acetate for Injection	Apr. 29	CI
Nicomac Machinery and RP Advisory Services Reportedly Likely to Sell 4.4% Stake in Gland Pharma via Block Deals	Apr. 08	CI
Gland Pharma Gets US FDA Approval for Eribulin Mesylate Injection	Apr. 08	MT
Gland Pharma Limited Receives Approval from the United States Food and Drug Administration for Eribulin Mesylate Injection 0.5 Mg/ML Single Dose Vial	Apr. 06	CI
Gland Pharma's Consolidated Profit Drops in Fiscal Q3	Feb. 15	MT
Gland Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	Feb. 14	CI
Gland Pharma Gets Establishment Inspection Report from US FDA for Pashamylaram Unit	Nov. 24	MT
Gland Pharma Limited Receives Tentative Approval for Angiotensin II Injection	Nov. 15	CI
Abbott India's Q2 profit climbs on strong sales	Nov. 09	RE
Gland Pharma Gets US FDA's EIR Report Closing Inspection of Visakhapatnam, India Unit	Nov. 08	MT
Indian shares set to open marginally higher	Nov. 06	RE

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Gland Pharma Limited

Equities

GLAND

INE068V01023

Highlights

Filters